Renal mucormycosis following COVID-19 treatment with immune modulators: a case report

Authors

  • Deepak Chaudhary Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Ashish Behera Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Navneet Sharma Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

DOI:

https://doi.org/10.18502/fem.v6i1.7684

Keywords:

Case Reports; COVID-19; Immunosuppression; Mucormycosis; Renal Insufficiency

Abstract

Mucormycosis is an opportunistic fungal infection that occurs primarily in immunocompromised individuals, usually affecting the rhino-orbital areas followed by the lungs. This case report presents renal mucormycosis in a young man after COVID-19 pneumonia that escalates the need for regular follow-up of COVID-19 patients. Post-COVID-19 fungal infections are on a steep rise, and the increased use of steroids and immune modulators for COVID-19-associated immune dysregulation and cytokine syndrome increases the risk among patients treated for COVID-19.

Published

2021-11-07

Issue

Volume (6) issue (1)

Section

Articles